HCA Healthcare Expects Q2 Adjusted Earnings, Revenue to Rise; Updates 2026 Guidance
HCA Healthcare (HCA) reported preliminary Q2 adjusted earnings Tuesday of $7.59 per diluted share, up from $6.84 a year earlier. Analysts polled by FactSet expect $7.53. Revenue for the quarter ended June 30 is expected to rise to $20.23 billion, from $18.61 billion a year ago. Analysts expect $19.47 billion. The company cut its 2026 adjusted diluted EPS guidance to a range of $28.70 to $30.50, from $29.10 to $31.50 previously. Analysts polled by FactSet expect $30.36. HCA Healthcare tightened its full-year revenue guidance to a range of $77 billion to $79.5 billion, compared with prior range of $76.5 billion to $80 billion. Analysts expect $78.6 billion. The company said it revised its key assumptions related to the pretax hit from payer mix shifts due to health insurance exchanges coverage losses. Shares of HCA Healthcare were down more than 10% in premarket activity Tuesday.
Story updates
HCA Healthcare (HCA) reported preliminary Q2 adjusted earnings Tuesday of $7.59 per diluted share, up from $6.84 a year earlier.
Analysts polled by FactSet expect $7.53.
Revenue for the quarter ended June 30 is expected to rise to $20.23 billion, from $18.61 billion a year ago.
Analysts expect $19.47 billion.
The company cut its 2026 adjusted diluted EPS guidance to a range of $28.70 to $30.50, from $29.10 to $31.50 previously.
Analysts polled by FactSet expect $30.36.
HCA Healthcare tightened its full-year revenue guidance to a range of $77 billion to $79.5 billion, compared with prior range of $76.5 billion to $80 billion.
Analysts expect $78.6 billion.
The company said it revised its key assumptions related to the pretax hit from payer mix shifts due to health insurance exchanges coverage losses.
Shares of HCA Healthcare were down more than 10% in premarket activity Tuesday.